학술논문

TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma
Document Type
Article
Source
In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, 1 April 2024, 23(4):532-540)
Subject
Language
English
ISSN
15388514
15357163